News
Events
About Pompe Disease
Symptoms
Diagnosis
Pompe Registry
Resources
Patient-Focused Publications
Patients Helping Patients
Research Papers
Publications for Physicians
Testimonials
International Pompe Day
IPA Erasmus Pompe Survey
About the IPA
IPA Board
IPA Members & Contacts
IPA Community Advisory Board
IPA Reviews & Reports
IPA Conferences
IPA Position Papers
Contact
Events
Read our news
About Pompe Disease
Symptoms
Diagnosis
Pompe Registry
Resources
Patient-Focused Publications
Patients Helping Patients
Research Papers
Publications for Physicians
Testimonials
International Pompe Day
IPA Erasmus Pompe Survey
About the IPA
IPA Board
IPA Members & Contacts
IPA Community Advisory Board
IPA Reviews & Reports
IPA Conferences
IPA Position Papers
Contact us
IMPORTANT MYOZYME SUPPLY INFORMATION HAS BEEN RELEASED (EU VERSION)
The following informations are relevant to the Supply Situation of Myozyme. The documents below represent guidance to physicians...
Author:
IPA
Archive
January 14, 2009
IMPORTANT MYOZYME SUPPLY INFORMATION HAS BEEN RELEASED (GLOBAL VERSION)
The following documents are relevant to the Supply Situation. The documents below represent guidance to physicians and patients...
Author:
IPA
Archive
January 14, 2009
Pompe Program Update
The US Food and Drug Administration (FDA) has informed Genzyme that the FDA plans an accelerated approval for...
Author:
Genzyme
Archive
November 16, 2008
Myozyme Produced at the 2000 L Bioreactor Scale to Receive Accelerated Approval
New PDUFA Date Set for February 28, 2009 Genzyme Corporation (Nasdaq: GENZ) today announced that the FDA plans...
Author:
Genzyme
Archive
November 16, 2008
Pompe Program Update
Click here to view. (PDF, 12 kB)
Author:
Genzyme
Archive
November 9, 2008
Amicus Therapeutics Begins Phase 2 Clinical Trial of AT2220 in Pompe Disease
CRANBURY, N.J., June 3, 2008—Amicus Therapeutics, a biopharmaceutical company developing small molecule, orally-administered pharmacological chaperones for the treatment...
Author:
Amicus
Archive
June 2, 2008
Genzyme Provides Update on Myozyme® Manufacturing
This article provides a link to the pdf version of Genzyme’s press release regarding Myozyme manufacturing. CAMBRIDGE, MA...
Author:
Genzyme
Archive
April 21, 2008
Pompe Program Update
Download the April 2008 Pompe Program Update (PDF, 24 kB)
Author:
Genzyme
Archive
April 20, 2008
January 2008 Myozyme Supply Update
This update contains important information concerning the supply of Myozyme in the United States. Download the January 2008...
Author:
Genzyme
Archive
January 14, 2008
Genzyme Study of Myozyme® for Late-Onset Pompe Patients
CAMBRIDGE, Mass. – Genzyme Corp. (Nasdaq: GENZ) announced today that its Late Onset Treatment Study (LOTS) of Myozyme®...
Author:
Genzyme
Archive
December 12, 2007
1
…
31
32
33
34
35
…
38